DEMENTIA, MILD

This study tests whether a device that delivers light and sound stimulation for 60 minutes each day can slow the decline in memory and daily living skills in people with mild to moderate Alzheimer's disease. About 670 participants will use either the active device or a sham (inac…

This study tests whether a daily pill called Xanamem can safely help people with mild or moderate Alzheimer's dementia. About 247 adults aged 50 and older will receive either Xanamem or a placebo for 36 weeks, with an option to continue treatment for up to 108 weeks. The goal is …

This study is testing a new automated tool that helps primary care doctors quickly screen older adults for early memory and thinking problems. The tool uses simple symbol matching and voice tasks on an iPad to give a risk score. Researchers hope it will make screening easier and …

This study uses special brain scans (tau PET) to measure how anti-amyloid therapy changes tau protein buildup in people with mild Alzheimer's disease. Researchers will track 135 adults aged 50-90 who are already receiving anti-amyloid treatment at Mayo Clinic. The goal is to bett…

This study looked at whether giving older adults (ages 60-79) personalized advice and extra support helps them follow brain-healthy habits like a Mediterranean diet, exercise, and staying socially active. About 95 participants with mild memory concerns or at risk for cognitive de…

This study checks if a set of thinking and memory tests usually done in person can be given remotely with the help of an examiner. Researchers will compare results from in-person and computer-based versions in 14 adults aged 50-90 with mild dementia. The goal is to make these ass…